Our study highlights an interaction among CD8+ T cells infiltration, PD-L1 expression, and CD44+/CD133+ CSCs existence, thus providing a rationale for designing ideal combination cancer therapies based on tumor immunology. This evidence concerns the gene CD8A and neoplasm.